Dr. Tanna will kick off the new monthly subspecialty education series with a virtual session on September 9, 2025, focused on ...

Course director Robert S. Feder, MD, shares how the monthly Zoom sessions aim to deliver clinical pearls and foster ...

The acquisition includes the noninvasive Valeda PBM device for the treatment of early and intermediate dry age-related ...

Roche's Contivue platform gains EU CE mark, offering innovative treatment for neovascular AMD with fewer injections and ...

OpZira Inc. launches innovative ophthalmic diagnostic tools, enhancing early detection and monitoring of ocular diseases for ...

VirtuaLens revolutionizes cataract care with its VR IOL Simulator, empowering patients to make informed lens choices through ...

This marks the first time that the TearCare System has been included in the TFOS DEWS III Management and Therapy Report.

A study reveals similar risks of sight-threatening diabetic retinopathy in pregnant women with type 1 diabetes compared to ...

Outlook Therapeutics seeks FDA clarity on ONS-5010 after a complete response letter, aiming to address efficacy concerns for ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

In addition to Thompson joining the board of directors, EyeCool also announced the members joining its newly formed medical ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.